Golgi apparatus, endoplasmic reticulum and mitochondrial function implicated in Alzheimer's disease through polygenic risk and RNA sequencing.
Journal
Molecular psychiatry
ISSN: 1476-5578
Titre abrégé: Mol Psychiatry
Pays: England
ID NLM: 9607835
Informations de publication
Date de publication:
03 2023
03 2023
Historique:
received:
08
08
2022
accepted:
14
12
2022
revised:
12
12
2022
pubmed:
29
12
2022
medline:
15
3
2023
entrez:
28
12
2022
Statut:
ppublish
Résumé
Polygenic risk scores (PRS) have been widely adopted as a tool for measuring common variant liability and they have been shown to predict lifetime risk of Alzheimer's disease (AD) development. However, the relationship between PRS and AD pathogenesis is largely unknown. To this end, we performed a differential gene-expression and associated disrupted biological pathway analyses of AD PRS vs. case/controls in human brain-derived cohort sample (cerebellum/temporal cortex; MayoRNAseq). The results highlighted already implicated mechanisms: immune and stress response, lipids, fatty acids and cholesterol metabolisms, endosome and cellular/neuronal death, being disrupted biological pathways in both case/controls and PRS, as well as previously less well characterised processes such as cellular structures, mitochondrial respiration and secretion. Despite heterogeneity in terms of differentially expressed genes in case/controls vs. PRS, there was a consensus of commonly disrupted biological mechanisms. Glia and microglia-related terms were also significantly disrupted, albeit not being the top disrupted Gene Ontology terms. GWAS implicated genes were significantly and in their majority, up-regulated in response to different PRS among the temporal cortex samples, suggesting potential common regulatory mechanisms. Tissue specificity in terms of disrupted biological pathways in temporal cortex vs. cerebellum was observed in relation to PRS, but limited tissue specificity when the datasets were analysed as case/controls. The largely common biological mechanisms between a case/control classification and in association with PRS suggests that PRS stratification can be used for studies where suitable case/control samples are not available or the selection of individuals with high and low PRS in clinical trials.
Identifiants
pubmed: 36577842
doi: 10.1038/s41380-022-01926-8
pii: 10.1038/s41380-022-01926-8
pmc: PMC10005937
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1327-1336Subventions
Organisme : Medical Research Council
ID : MC_PC_17112
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0902227
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0801418
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/T04604X/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K013041/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0300429
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P005748/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L023784/2
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L501517/1
Pays : United Kingdom
Organisme : RCUK | Medical Research Council (MRC)
ID : UKDRI-3003
Organisme : RCUK | Medical Research Council (MRC)
ID : MR/L010305/1
Informations de copyright
© 2022. The Author(s).
Références
Nat Genet. 2022 Apr;54(4):412-436
pubmed: 35379992
Nat Genet. 2013 Dec;45(12):1452-8
pubmed: 24162737
PLoS Genet. 2019 Nov 26;15(11):e1008519
pubmed: 31770365
Nat Metab. 2021 Nov;3(11):1476-1483
pubmed: 34750571
Transl Psychiatry. 2018 May 18;8(1):99
pubmed: 29777097
Nat Commun. 2021 Mar 12;12(1):1610
pubmed: 33712570
Am J Hum Genet. 2012 Nov 2;91(5):839-48
pubmed: 23103226
Sci Data. 2018 Sep 11;5:180185
pubmed: 30204156
Sci Data. 2016 Oct 11;3:160089
pubmed: 27727239
Lancet Neurol. 2018 Mar;17(3):241-250
pubmed: 29397305
Neurobiol Dis. 2021 Jun;153:105303
pubmed: 33631273
Nucleic Acids Res. 2012 May;40(10):4288-97
pubmed: 22287627
Trends Neurosci. 2017 Oct;40(10):592-602
pubmed: 28962801
Genome Biol. 2014;15(12):550
pubmed: 25516281
Am J Pathol. 2009 Nov;175(5):1810-6
pubmed: 19834068
Ann Neurol. 2019 Sep;86(3):427-435
pubmed: 31199530
Gigascience. 2015 Feb 25;4:7
pubmed: 25722852
Endocr Rev. 2019 Dec 1;40(6):1500-1520
pubmed: 31322649
Bioinformatics. 2021 Sep 29;37(18):3048-3050
pubmed: 33677499
Am J Hum Genet. 2019 Jan 3;104(1):21-34
pubmed: 30554720
PLoS One. 2010 Nov 15;5(11):e13950
pubmed: 21085570
Nat Commun. 2021 Apr 19;12(1):2311
pubmed: 33875655
Nat Genet. 2021 Sep;53(9):1276-1282
pubmed: 34493870
Open Biol. 2018 Apr;8(4):
pubmed: 29695619
Nat Neurosci. 2020 Mar;23(3):311-322
pubmed: 32112059
BMC Bioinformatics. 2004 Dec 09;5:193
pubmed: 15588298
Brain Commun. 2019;1(1):fcz022
pubmed: 32274467
JAMA. 2019 May 14;321(18):1820-1821
pubmed: 30958510
Front Genet. 2019 Oct 25;10:1021
pubmed: 31708967
Nature. 2009 Aug 6;460(7256):748-52
pubmed: 19571811
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Nat Genet. 2019 Mar;51(3):414-430
pubmed: 30820047
EMBO J. 2012 Nov 5;31(21):4095-7
pubmed: 23047154
Nat Genet. 2018 Sep;50(9):1219-1224
pubmed: 30104762
Nat Genet. 2019 Mar;51(3):404-413
pubmed: 30617256
Neurobiol Dis. 2021 Sep;157:105428
pubmed: 34153464
Front Aging Neurosci. 2018 May 23;10:153
pubmed: 29875655
Hum Mol Genet. 2020 Oct 10;29(17):2899-2919
pubmed: 32803238
Brain. 2015 Dec;138(Pt 12):3673-84
pubmed: 26490334
Int J Alzheimers Dis. 2011;2011:305395
pubmed: 21922047
Sci Data. 2018 Aug 07;5:180142
pubmed: 30084846
Genome Biol. 2013;14(10):R115
pubmed: 24138928
Transl Psychiatry. 2019 May 24;9(1):154
pubmed: 31127079
Cell. 2013 Apr 25;153(3):707-20
pubmed: 23622250
Methods Mol Biol. 2020;2117:207-215
pubmed: 31960380